. 2024 Apr 5;103:105091. doi: 10.1016/j.ebiom.2024.105091

Table 2.

Multivariate meta-regression analysis.

Covariate	Type	Classification	N	Effect size (95% CI)	I²	β (95% CI)	p-value
End user involvement	Developmental feature	Yes	21	−0.20 (−0.33, −0.06)	50%	0.14 (−0.07, 0.34)	0.184
End user involvement	Developmental feature	No	33	−0.45 (−0.57, −0.32)	73%	0.14 (−0.07, 0.34)	0.184
2.3 Self-monitoring of behaviour	BCT	Yes	37	−0.46 (−0.57, −0.34)	68%	−0.22 (−0.44, −0.01)	0.044
2.3 Self-monitoring of behaviour	BCT	No	17	−0.15 (−0.30, 0.00)	59%	−0.22 (−0.44, −0.01)	0.044
2.4 Self-monitoring of outcome(s) of behaviour	BCT	Yes	35	−0.45 (−0.57, −0.33)	70%	−0.07 (−0.29, 0.15)	0.543
2.4 Self-monitoring of outcome(s) of behaviour	BCT	No	19	−0.20 (−0.36, −0.05)	66%	−0.07 (−0.29, 0.15)	0.543
Taking medication	Target behaviour	Yes	22	−0.55 (−0.74, −0.35)	67%	−0.20 (−0.39, 0.00)	0.050
Taking medication	Target behaviour	No	32	−0.28 (−0.38, −0.17)	69%	−0.20 (−0.39, 0.00)	0.050

Note: N = number of studies.